You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Randomized controlled multicenter trials of drug: and explain in detail?
Ans- C Phase 3 - randomized controlled multicenter trials REF: Goodman and Gillman's 11th edition page 82, http://en.wikipedia.org/wiki/Clinical_trial, s/ctphases.html CLINICAL TRIAL: Designation Study Population Sample size Phase 0 human microdosing studies pharmacodynamics and pharmacokinetics (no data on safety or efficacy, being by definition a subtherapeutic dose) Healthy volunteers 10 to 15 Phase 1 first stage of testing in human subjects safety (pharmacovigilance), dose-ranging tolerability, pharmacokinetics, and pharmacodynamics Healthy volunteers or individuals with target disease 20-100 Phase 2 efficacy (how well the drug works), dosing requirements (how much drug should be given), toxicity and continue Phase I safety assessments individuals with target disease 100-300 Phase 3 randomized controlled multicenter trials, "pre-marketing phase" how effective the drug is, in comparison ivith current gold standard' treatment (most expensive, time-consuming and difficult trials) individuals with target disease 300-3,000 or more Phase 4 Postmarketing surveillance Trial safety surveillance (pharmacovigilance, designed to detect any rare or long-term adverse effects) individuals with target disease as well as new age groups, genders, etc. Thousands